印度提议终止乙型、丙型肝炎和艾滋病毒的多余血液检测,以符合全球标准。 India proposes ending redundant blood tests for Hepatitis B, C, and HIV to align with global standards.

联邦卫生部提议取消印度对血液制品的多余病毒检测,使国家条例符合国际标准。 The Union Health Ministry has proposed eliminating redundant viral testing of blood products in India, aligning national regulations with international standards. 1945年《毒品规则》修正案草案将取消在最终血浆衍生产品中反复进行的乙型肝炎、丙型肝炎和艾滋病毒检测,因为这些检测已在集合血浆阶段进行筛查。 The draft amendment to the Drugs Rules, 1945, would remove repeated tests for Hepatitis B, Hepatitis C, and HIV in final plasma-derived products, as these are already screened at the pooled plasma stage. 改革的目的是减少合规负担,支持统一监管,并在不损害质量的情况下维护患者的安全。 The change aims to reduce compliance burdens, support regulatory harmonization, and maintain patient safety without compromising quality. 目前正在征求公众关于该草案的反馈意见。 Public feedback on the draft is currently being sought.